Status:

COMPLETED

Safety and Feasibility Study of the Eddii Mobile Application

Lead Sponsor:

Eddii, Inc.

Conditions:

Type-1 Diabetes

Eligibility:

All Genders

5-12 years

Phase:

NA

Brief Summary

The study is designed to measure the safety and feasibility of the Eddii mobile app for children living with Type-1 diabetes and using a CGM (Continuous Glucose monitor).

Detailed Description

Wearable continuous glucose monitoring (CGM) sensors have revolutionized diabetes management over the past decade. By providing blood glucose (BG) concentration measurements continuously over consecut...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Pediatric Volunteers)
  • Subject must meet all of the following to be enrolled.
  • Volunteer, or their Authorized Representative, is willing and able to provide written informed consent, including authorization to release health information
  • Volunteer is \> 5 years and \< 12 years of age (inclusive) at time of consent
  • Volunteer has been diagnosed with Type 1 diabetes
  • Volunteer has been utilizing the Dexcom continuous glucose monitor for a minimum of 6 months prior to enrollment in the study
  • Volunteer must use the Dexcom mobile application
  • Volunteer has a parent or legal guardian willing to participate in the study
  • Volunteer must have access to and use an iOS smart phone, iPhone 10 model or above
  • Parent / Guardian Volunteers:
  • Subject must meet all of the following to be enrolled.
  • Volunteer is willing and able to provide written informed consent, including authorization to release health information
  • Volunteer has a child that meets study inclusion criteria and is willing to participate in the study
  • Volunteer lives with a child that meets study inclusion criteria and is willing to participate in the study
  • Volunteer is willing to be responsible for management of the Eddii mobile application use
  • Volunteer must have and use an iOS smart phone device
  • Exclusion Criteria:
  • \- EXCLUSION CRITERIA (Pediatric Volunteers)
  • Subject will be excluded if any of the below are present.
  • Volunteer is unwilling or unable to provide written informed consent and/or does not have an authorized representative who can provide consent on their behalf
  • Volunteer does not have access to an iOS smartphone device
  • Volunteer does not have access to the internet
  • Volunteer is enrolled in another research study at the time of enrollment
  • EXCLUSION CRITERIA (Parents / Guardians) Subject will be excluded if any of the below are present.
  • Volunteer is unwilling or unable to provide written informed consent and/or does not have an authorized representative who can provide consent on their behalf
  • Volunteer does not have access to an iOS smartphone device
  • Volunteer does not have access to the internet
  • Volunteer is enrolled in another research study at the time of enrollment

Exclusion

    Key Trial Info

    Start Date :

    January 2 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 31 2022

    Estimated Enrollment :

    92 Patients enrolled

    Trial Details

    Trial ID

    NCT05205876

    Start Date

    January 2 2021

    End Date

    August 31 2022

    Last Update

    October 5 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Eddii, inc.

    New York, New York, United States, 10016